IDO1 and cardiac hypertrophy: Through a series of in vivo and in vitro experiments, they demonstrated that knockout of IDO1 and down-regulating KYN could mitigate pathological myocardial hypertrophy by modulating the expression of GATA4 (GATA binding protein 4) via AhR regulation.